Bacteremic shock due to gram-negative bacilli. Some concepts of pathogenesis and management based on recent developments.
D000818:Animals; D001442:Bacteroides Infections / Q000188:drug therapy; D002701:Chloramphenicol / Q000627:therapeutic use; D004754:Enterobacter; D004927:Escherichia coli Infections / Q000188:drug therapy; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D007710:Klebsiella Infections / Q000188:drug therapy; D011113:Polymyxins / Q000627:therapeutic use; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D018805:Sepsis / Q000150:complications* / Q000188:drug therapy; D012705:Serratia; D012772:Shock, Septic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D013752:Tetracycline / Q000627:therapeutic use
D005839:Gentamicins; D011113:Polymyxins; D007612:Kanamycin; D002701:Chloramphenicol; D013752:Tetracycline